+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alzinova AB - logo

Alzinova AB - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

Alzinova AB is Swedish biotechnology enterprise engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company was founded in 2011 by the inventors of the AβCC peptide technology (patent pending) and MIVAC Development AB in close collaboration with the holding company at the University of Gothenburg in Sweden, GU Ventures AB. It is headquartered in Gothenburg, Sweden.

Alzheimer's Disease - Pipeline Review, H1 2019 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2019

  • Drug Pipelines
  • 1429 Pages
  • 6 Results (Page 1 of 1)
Loading Indicator